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Lipopolysaccharides are anchored to the outer membrane of
Gram-negative bacteria by a hydrophobic moiety known as lipid
A, which potently activates the host innate immune response.
Lipid A of Bordetella pertussis, the causative agent of whooping
cough, displays unusual structural asymmetry with respect to
the length of the acyl chains at the 3 and 3 positions, which are
3OH-C10 and 3OH-C14 chains, respectively. Both chains are
attached by the acyltransferase LpxA, the first enzyme in the
lipid A biosynthesis pathway, which, in B. pertussis, has limited
chain length specificity. However, this only partially explains
the strict asymmetry of lipid A. In attempts to modulate the
endotoxicity of B. pertussis lipid A, here we expressed the gene
encoding LpxA from Neisseria meningitidis, which specifically
attaches 3OH-C12 chains, in B. pertussis. This expression was
lethal, suggesting that one of the downstream enzymes in the
lipid A biosynthesis pathway in B. pertussis cannot handle pre-
cursors with a 3OH-C12 chain. We considered that the UDP-
diacylglucosamine pyrophosphohydrolase LpxH could be re-
sponsible for this defect as well as for the asymmetry of
B. pertussis lipid A. Expression of meningococcal LpxH in
B. pertussis indeed resulted in new symmetric lipid A species
with 3OH-C10 or 3OH-C14 chains at both the 3 and 3 posi-
tions, as revealed by MS analysis. Furthermore, co-expression of
meningococcal lpxH and lpxA resulted in viable cells that incor-
porated 3OH-C12 chains in B. pertussis lipid A. We conclude
that the asymmetry of B. pertussis lipid A is determined by the
acyl chain length specificity of LpxH.
The outer membrane of Gram-negative bacteria is an asym-
metrical bilayer consisting of phospholipids and lipopolysac-
charides (LPS)2 in the inner and outer leaflets, respectively. It
functions as a permeability barrier for harmful compounds
from the environment. LPS is responsible for the barrier func-
tion of the membrane. It consists of three moieties: lipid A,
which anchors LPS in the membrane; a core oligosaccharide;
and a long polysaccharide consisting of repeating units, known
as the O antigen. This O antigen, however, is lacking in many
bacteria, including Bordetella pertussis.
Lipid A, also known as endotoxin, is an important signaling
molecule for the innate immune system that is recognized by
Toll-like receptor 4 (TLR4) and the co-receptor MD-2. Its
structure and biosynthesis pathway are generally well con-
served among Gram-negative bacteria (1). In Escherichia coli, it
consists of a glucosamine disaccharide, phosphorylated at the 1
and 4 positions, and 3-hydroxy (3OH) acyl chains linked via
amide bonds at the 2 and 2 positions and via ester bonds at the
3 and 3 positions (Fig. 1A). Secondary acyl chains are esterified
to the hydroxyl groups of the primary acyl chains at the 2 and
3 positions, generating the characteristic hexa-acylated bis-
phosphorylated lipid A of E. coli. Lipid A biosynthesis requires
nine conserved enzymes (Fig. 2). Biosynthesis is initiated with
the transfer of a 3OH-acyl chain from the acyl carrier protein to
the 3 position of GlcNAc in the activated sugar UDP-GlcNAc
by the acyltransferase LpxA. The resulting product is deacety-
lated by LpxC and subsequently acylated with a 3OH-acyl chain
at the 2 position by LpxD, generating UDP-2,3-diacylgluco-
samine (UDP-DAG). LpxH then removes a UMP molecule
from a portion of the pool of UDP-DAG molecules, generating
lipid X, and one lipid X molecule is linked with a UDP-DAG
molecule by LpxB. The resulting product is phosphorylated at
the 4 position by LpxK, generating lipid IVA. After transfer of
two 3-deoxy-D-manno-oct-2-ulosonic acid residues to the 6
position by WaaA, the secondary acyl chains are added by the
late acyltransferases LpxL and LpxM (1).
Although the biosynthesis route is well conserved, some var-
iation in the lipid A structure is observed between different
Gram-negative bacteria. Such variation, which can have pro-
found effects on signaling via the TLR4/MD-2 complex, is in
part due to modifications that occur during or after transport of
the LPS molecules to the outer membrane and include, among
others, acylation, deacylation, and dephosphorylation events
(2, 3). Part of the variation, however, is already introduced dur-
ing the general biosynthesis pathway. For example, comparison
of the structures of lipid A from E. coli and Neisseria meningi-
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tidis shows a different position of one of the secondary acyl
chains and a different length of several acyl chains (Fig. 1A).
Acyl chain length is determined by hydrocarbon rulers in the
acyltransferases (4, 5). Thus, although LpxA of E. coli mediates
the incorporation of 3OH-C14 chains at the 3 and 3 positions
of lipid A, LpxA of N. meningitidis (LpxANm) incorporates
3OH-C12 chains. Because acyl chain length influences the tox-
icity of lipid A (6, 7), the heterologous expression of acyltrans-
ferases can be used in vaccine development projects to modu-
late lipid A acyl chain length and, thereby, the reactogenicity of
vaccine formulations (8).
We are following this approach in the development of a
third-generation vaccine against B. pertussis, the causative
agent of whooping cough. A whole cell– based vaccine against
this pathogen, which was introduced in the 1950s, was effective,
but it was too reactogenic and therefore replaced with subunit
vaccines around the start of the millennium (9). However, these
vaccines are insufficiently effective considering the current
epidemics of pertussis in industrialized countries where they
are implemented, despite high vaccine coverage (10). One
approach to solve the problem could be the development of
new, less reactogenic cellular vaccines. Because LPS is a major
contributor to the toxicity of cellular B. pertussis vaccines (11),
engineering of the lipid A moiety could offer a solution. B. per-
tussis lipid A has five acyl chains (12). Curiously, the lengths of
the acyl chains at the 3 and 3 positions are different (Fig. 1B),
even though LpxA is responsible for the incorporation of both
of them. This asymmetry is only partially explained by the relaxed
acyl chain specificity of B. pertussis LpxA (LpxABp), which medi-
ates the incorporation of 3OH-acyl chains of various lengths at
both the 3 and the 3 position when expressed in E. coli (13). In this
study, we intended to express LpxANm in B. pertussis to manipu-
late the reactogenicity of its LPS, but this turned out to be lethal.
This observation put us on track to understand the enigmatic
asymmetry in B. pertussis lipid A with respect to the length of the
acyl chains at the 3 and 3 positions.
Results and discussion
Heterologous expression of lpxANm in B. pertussis is lethal
To modulate LPS toxicity, we intended to express lpxANm in
B. pertussis, which was expected to result in substitution of the
3OH-C10 and 3OH-C14 acyl chains at the 3 and 3 positions,
respectively, of B. pertussis lipid A by two 3OH-C12 chains (Fig.
1B). The lpxANm gene was cloned into the broad host range
expression vector pMMB67EH under control of the tac pro-
moter, and its expression was evaluated in the cloning host
E. coli BL21(DE3). RT-PCR assays confirmed the presence of
transcripts of the lpxANm gene when the bacteria were grown
with isopropyl 1-thio--D-galactopyranoside (IPTG) (Fig. S1A).
Expression of lpxANm did not affect the growth of E. coli. The
plasmid was then transferred by conjugation to B. pertussis
strain B213. Although some ampicillin- and nalidixic acid–
resistant transconjugants were obtained, these colonies failed
Figure 1. Lipid A structures. A, comparison of the structures of lipid A from E. coli K-12 and from N. meningitidis H44/76. B, structure of lipid A from B. pertussis
strain B213 and that expected by expression of lpxANm in this strain. The acyl chains that are expected to replace those of the WT in the recombinant strain are
indicated in red.
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to grow after replating on growth medium containing ampicil-
lin and nalidixic acid. Thus, apparently, even in the absence of
IPTG, leaky expression of lpxANm is already lethal in B. pertus-
sis, although this is not the case in E. coli.
Previously, it has been noticed that incorporation of shorter
acyl chains, i.e. 3OH-C10 or 3OH-C12, at the 3 position of
B. pertussis lipid A is possible without affecting viability by a
mutation in the endogenous lpxABp gene present in naturally
occurring B. pertussis isolates (14, 15). Apparently, the problem
is that B. pertussis cannot incorporate longer acyl chains at the
3 position. Thus, both the lethality of lpxANm expression and
the asymmetry of B. pertussis lipid A could be explained by
assuming that LpxHBp, which releases UMP from a portion of
the pool of UDP-DAG molecules (Fig. 2), is highly selective for
UDP-DAG molecules that have 3OH-C10 at the 3 position of
the sugar moiety. In this way, glucosamine with a 3OH-C10 at
the 3 position would always end up at the reducing end of the
lipid A disaccharide, whereas the remaining pool of UDP-DAG
molecules with longer acyl chains would end up at the nonre-
ducing end. In addition, when the pool of UDP-DAG molecules
with 3OH-C10 is limited because of heterologous expression of
an LpxA that only incorporates longer 3OH-acyl chains, such as
that of N. meningitidis, this would become lethal. An alterna-
tive explanation would be that substrate selectivity resides in
LpxBBp, which then should selectively incorporate only lipid X
molecules with a 3OH-C10 chain at the reducing end in the
lipid A precursors (Fig. 2). However, in the absence of LpxH
selectivity, numerous lipid X molecules with longer 3OH-acyl
chains at the 3 position would be generated, which would be
lost for further incorporation into lipid A precursors, which
seems highly unlikely.
Heterologous expression of lpxH from N. meningitidis
(lpxHNm) breaks lipid A asymmetry in B. pertussis
If our hypothesis that the rigorous asymmetry of lipid A of
B. pertussis at the 3 and 3 positions is determined by substrate
Figure 2. Schematic representation of the Raetz pathway for the synthesis of Kdo2-lipid A. Shown is the pathway as operative in E. coli K-12 according to
Ref. 1. The pathway is composed of nine conserved enzymes located in the cytoplasm or the cytoplasmic membrane. The chemical structure of substrates and
products of the reactions is indicated. From the top left, arrows show the order of reactions, and the corresponding enzymes are colored according to the
resulting structural modification of the product. Where appropriate, the names of substrates or products are specified.
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specificity of LpxHBp is correct, then one would expect that the
expression of a heterologous LpxH would break this asymme-
try. To test this hypothesis, we cloned the lpxHNm gene into
plasmid pMMB67EH, whereby a His tag was engineered at the
C terminus to facilitate protein detection. Western blotting
revealed that the recombinant protein was produced in E. coli
strain BL21(DE3) even when the strain was grown in the
absence of IPTG (Fig. S1B), and no growth defects were
observed. The plasmid was then transferred to B. pertussis
strain B213, where again protein expression was confirmed by
Western blotting (Fig. S1B). However, the growth rate of B213
was affected by expression of lpxHNm (Fig. S1C). LPS was iso-
lated from the WT strain and from a transconjugant grown in
the presence of IPTG. Analysis of the lipid A structure of the
WT strain by nano-electrospray ionization (ESI)–MS showed a
major peak at m/z 1557.97 (Fig. 3A), which corresponds with
the expected bis-phosphorylated penta-acylated lipid A (Fig.
1B). The spectrum of B213-pLpxHNm lipid A revealed, besides
the ion at m/z 1557.97, two additional major ions at m/z
1501.91 and m/z 1614.03 (Fig. 3B), consistent with the presence
of lipid A species with two 3OH-C10 and two 3OH-C14,
respectively, at the 3 and 3 positions. These data clearly show
that longer acyl chains can be incorporated at the 3 position and
shorter acyl chains at the 3 position in B. pertussis expressing
lpxHNm and, thus, that substrate specificity of LpxHBp is
responsible for the observed lipid A asymmetry. It should be
noted that, because apparently any available acyl chain can be
incorporated at the 3 and 3 positions in the recombinant
strain, the major ion at m/z 1557.97 could consist of two species
in this strain, i.e. one with 3OH-C10 and 3OH-C14 at the 3 and
3 positions, respectively, like in the WT, and the other having
these acyl chains in the reversed positions. Indeed, in-source
collision-induced dissociation (CID) tandem MS (MS/MS)
analysis provided evidence of the presence of both species in
this ion (see supporting Results).
Co-expression of lpxHNm enables expression of lpxANm in
B. pertussis
We reasoned that lpxANm expression is lethal in B. pertussis
because the pool of UDP-DAG molecules with 3OH-C10
chains, which serve as substrates for LpxHBp, is too small in
such recombinant strains to generate sufficient lipid X for LPS
synthesis. Another explanation could be toxicity of accumu-
lated UDP-DAG molecules with longer acyl chains that cannot
be converted by LpxHBp, as reported for an Acinetobacter bau-
mannii lpxH knockout mutant (15). If either one of these expla-
nations is correct, then co-expression of lpxHNm should rescue
B. pertussis expressing lpxANm because it can also convert
UDP-DAG molecules with larger acyl chains at the 3 position
into lipid X. To test this possibility, we cloned the lpxHNm gene
into pMMB67EH-LpxANm in between the promoter and the
lpxANm gene. RT-PCR assays confirmed expression of both
genes in E. coli (Fig. S1A). The plasmid was then transferred to
B. pertussis strain B213, and viable transconjugants were
obtained, although their growth was reduced compared with
WT B213, resulting in about 2-fold lower optical density in the
stationary phase (Fig. S1C). This evidences that lpxHNm expres-
sion can compensate for the lethal effects of the expression of
lpxANm in B. pertussis and supports the hypothesis that sub-
strate specificity of LpxHBp is responsible for the impaired
growth of B. pertussis expressing lpxANm. The nano-ESI–MS
spectra of lipid A from the recombinant strain showed, besides
a large alteration in the relative abundance of the ions at m/z
1557.97 and 1501.91, a new major ion at m/z 1529.94 (Fig. 3C),
which corresponds with lipid A species with 3OH-C10 and
3OH-C12 chains at the 3 and 3 positions, respectively, or in the
reversed positions, as evidenced by CID-MS/MS (see expanded
results in supporting information file 2). Thus, the 3OH-C12
chains that are introduced in the lipid A biosynthesis pathway
by the heterologous LpxANm end up in the final product. It
should be noted that the ion at m/z 1557.97 in this case could
consist of three lipid A species, i.e. the WT with 3OH-C14 and
3OH-C10 at the 3 and 3 positions, respectively, a variant with
these chains in the reversed positions, and one with 3OH-C12
at both positions. CID-MS/MS indeed provided evidence for
the presence of all three variants in this ion (supporting
Results).
Structural analysis of substrate selection by LpxH
Recently, the crystal structures of LpxH from Haemophilus
influenzae and from Pseudomonas aeruginosa were both solved
in complex with the lipid X product of the enzyme (16, 17).
LpxH consists of two domains: a catalytic domain homologous
to metallophosphoesterases and a helical insertion domain,
dubbed the lid, inserted in the middle of the catalytic domain.
The catalytic domain of 180 residues is composed of two fac-
ing  sheets and four peripheral  helices. The lid is composed
of two long helices (helix 1 and helix 3) connected by a
short helix (helix 2) (Fig. S2). Lipid X locates in the crevice
between these two domains, with its phosphate group facing
Figure 3. Structural analysis of lipid A. A–C, negative-ion lipid A mass spec-
tra were obtained by in-source CID nano-ESI–FT–MS of intact LPS isolated
from cells of B213 (A), B213 expressing lpxHNm (B), and B213 expressing
lpxHNm and lpxANm (C). Bacteria were grown for 12 h in Verwey medium in the
presence of IPTG. A major singly deprotonated ion at m/z 1557.97 was inter-
preted as the typical B. pertussis lipid A structure: a diglucosamine (2 GlcN),
penta-acylated (three 3OH-C14, one 3OH-C1, and one C14) with two phos-
phate residues (2 P), as illustrated in Fig. 1B. Additional singly deprotonated
lipid A ions were detected in different derivatives, and their interpretations
are indicated. Only the m/z range covering lipid A ions is shown.
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the dinuclear metal (Mn2) center and the 2-N-linked acyl
chain buried in the hydrophobic cavity between the catalytic
domain and the lid, whereas the 3-O-linked chain reaches out of
this cavity and is associated with the surface of the lid. Align-
ments showed differences in LpxH of B. pertussis in this lid
domain (Fig. S2A). Structural modeling yielded reasonable
models of B. pertussis LpxH in complex with lipid X with either
3OH-C14 or 3OH-C10 chains at the 3 position (Fig. S2B).
Despite variations in the amino acid composition at the inter-
face with the acyl chain (Fig. S2C), no discernable difference in
conformational binding (Fig. S2B) or binding affinity of the two
lipid X species were observed (the average Haddock score
for 3OH-C10 and 3OH-C14 chains were 112  1.1 and
115.5  2.8, respectively). Notably, the terminal part of the
3OH acyl chain in one of the template structures also protrudes
from the complex, suggesting that there are no relevant specific
interactions with LpxH in the bound complex whose alteration
could promote selectivity. Thus, selectivity is most likely a
result of changes in binding kinetics not captured in our model.
Based on the suggested binding mode (16), the 3OH acyl chain
has to pass through the lid domain upon ligand binding. It is
thus possible that specificity is mediated by structural differ-
ences in the lid domain of B. pertussis, e.g. the differences in the
connection loops to helix 2 that hinder passage of acyl chains
exceeding C10. Possibly, molecular dynamics can give more
insight into the specific mechanism.
Consequence of breaking lipid A asymmetry on membrane
permeability
LPS is crucial for the permeability barrier imposed by the
outer membrane. To test the biological consequences of chang-
ing LpxH specificity, we incubated B. pertussis and derivatives
with a set of antibiotics (rifampicin, chloramphenicol, and van-
comycin) and determined bacterial survival. Rifampicin is a
large hydrophobic antibiotic that crosses the outer membrane
by diffusion via the hydrophobic pathway. In contrast, chlor-
amphenicol and vancomycin are hydrophilic. Although chlor-
amphenicol can cross the outer membrane by diffusion
through the porins, vancomycin is too large and requires mem-
brane disruptions to pass. WT B213 cells were significantly
more susceptible to rifampicin than its derivatives expressing
lpxHNm alone or in combination with lpxANm (Fig. 4). This
result indicates that the permeability barrier for hydrophobic
compounds imposed by the outer membrane is fortified by
expression of the heterologous lpxH, although we cannot rule
out the possibility that the reduced growth rate of the recom-
binant strains influences their rifampicin susceptibility. In con-
trast, expression of lpxHNm did not affect the strains’ suscepti-
bility to vancomycin and chloramphenicol (Fig. 4), indicating
that no breaches were generated in the outer membrane and
that the porin pathway for the uptake of hydrophilic com-
pounds was unaffected. The strain expressing both lpxHNm and
lpxANm was significantly more susceptible to chloramphenicol
and also appeared to be somewhat more susceptible to vanco-
mycin, but not significantly (Fig. 4). We also tested the suscep-
tibility of the bacteria to another large hydrophilic antibiotic,
bacitracin, but all strains were resistant to the highest concen-
tration tested (0.1 mg ml1).
Consequence of breaking lipid A asymmetry on bioactivity
We also analyzed the consequences of LpxHNm activity in
B. pertussis on TLR4 activation. When HEK-Blue reporter cells
expressing the human TLR4 receptor (hTLR4) or mouse TLR4
receptor (mTLR4) were incubated with B. pertussis LPS, LPS
from strain B213-pLpxHNm showed a similar activation of both
hTLR4 and mTLR4 as WT LPS (Figs. 5, A and B). It should be
noted, however, that lipid A in the recombinant strain is heter-
ogeneous (Fig. 3B). Hence, even if the bioactivity of some LPS
molecules may be changed relative to WT LPS, this is then
apparently compensated by altered bioactivity of other LPS
molecules in the recombinant cells.
Interestingly, the biological activity of LPS from B213-
pLpxHNm-LpxANm was impaired in the activation of hTLR4
and also, but to lesser extent, of mTLR4 (Fig. 5, A and B), pos-
sibly as consequence of the novel lipid A species with 3OH-C12
at the 3 and/or 3 positions produced by this mutant. The lack
of hTLR4 activation, despite the presence of also WT LPS in
this preparation, indicates that the novel species may have
antagonist activity. Thus, these data suggest that alteration of
the length of the acyl chains affects the activity of B. pertussis
LPS, which is consistent with previously described data
obtained with natural B. pertussis variants producing LPS with
a shorter acyl chain at the 3 position (14).
Conclusion
We have shown, for the first time, that the acyl chain length
in lipid A molecules is not only determined by the substrate
specificity of the acyltransferases but can also be influenced by
substrate specificity of other enzymes in the lipid A biosynthe-
sis pathway, i.e. LpxH. Asymmetric lipid A species, with respect
to acyl chain length, are also reported for other bacteria, e.g. in
Piscirickettsia salmonis, where the major lipid A species con-
tains 3OH-C14 and 3OH-C16 chains at the 2 and 2 positions,
respectively (18). However, a minor, symmetric lipid A species
was also detected in this species, with 3OH-C14 at both posi-
tions. These structures could be explained by a preference but
Figure 4. Antibiotic sensitivity assays. Bacteria were grown in Verwey
medium in the presence of IPTG until the exponential phase and incubated
with rifampicin, chloramphenicol, or vancomycin for 1 h. Subsequently, they
were plated on BG blood plates, and colonies were counted after 48 h. Bacte-
rial survival is expressed as the percentage of bacteria relative to the
untreated control for each strain, and standard deviations are depicted. Data
represent results of at least three independent experiments. Statistically sig-
nificant differences were analyzed with GraphPad Prism 6 (unpaired statisti-
cal t test). *, p  0.05; **, p  0.01.
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no strict specificity of LpxH for UDP-DAG molecules with
3OH-C16 at the 2 position in this organism. As another exam-
ple, Francisella novicida produces two LpxD enzymes, one
incorporating 3OH-C18 at 37 °C and the other incorporating
3OH-C16 at 18 °C, resulting in symmetric lipid A species at both
temperatures (19). However, at intermediate temperature (25 °C),
asymmetric lipid A species are produced with 3OH-C18 and
3OH-C16 at the 3 and 3 positions, respectively. This could be
explained by a preference, but no strict specificity, of LpxH for
UDP-DAG molecules with 3OH-C16 at the 2 position. The
knowledge that LpxH can display chain length preference or spec-
ificity introduces a new tool that can be used to modulate the com-
position and, therefore, the reactogenicity of lipid A.
Experimental procedures
Plasmids, strains, and growth conditions
The plasmids and strains used in this study are listed in Table
S1. B. pertussis strains were cultured on Bordet–Gengou (BG)
agar (Difco) supplemented with 15% defibrinated sheep blood
(Biotrading) for 48 h at 35 °C. To grow the bacteria in liquid
cultures, bacteria were collected from BG medium and diluted
in Verwey medium (20) to an A590 of 0.05 and incubated with
constant shaking at 175 rpm. After growth, bacteria were heat-
inactivated for 1 h at 60C, harvested by centrifugation at
3500  g for 10 min, and stored at 20C. E. coli strains were
grown in lysogeny broth or lysogeny broth agar at 37 °C. For all
strains, media were supplemented with ampicillin (100 g
ml1) and/or nalidixic acid (50 g ml1) when required for
selection and with 0.1 or 1 mM IPTG for E. coli or B. pertussis,
respectively, to induce gene expression.
Genetic manipulations
Genomic DNA was obtained by resuspending bacteria in
water to an A550 of 2.0. After boiling for 5 min, the cell debris
was pelleted in an Eppendorf 5424 centrifuge for 10 min at
maximal speed. The supernatant was used as template DNA for
PCRs. Primers are listed in Table S2. PCRs were performed
using High Fidelity Polymerase (Roche Diagnostics GmbH).
PCR mixtures consisted of 1 l of template DNA, 200 M
dNTPs (Fermentas), 0.25 M of different primer combinations,
0.5 units of DNA polymerase, and PCR buffer. PCR mixtures
were incubated in a thermocycler for 10 min at 95 °C for DNA
denaturation, followed by 30 cycles of 1 min at 95 °C, 0.5 min at
58 °C, and elongation at 72 °C for 1 min per kb of the expected
amplicon size. The PCRs were finalized by an elongation step
for 10 min at 72 °C. The PCR products were analyzed on 1%
agarose gels. The lpxA and lpxH genes from N. meningitidis
strain H44/76 (21) were amplified by PCR and cloned into the
broad host range expression vector pMMB67EH. PCR products
and plasmids were purified using the Clean-Up System and
Plasmid Extraction kit, respectively (both from Promega). Puri-
fied plasmid and PCR products were digested with restriction
enzymes (Fermentas) whose sites were included in the primers
(Table S2) and subsequently ligated together. To generate
pMMB67EH-LpxHNm-LpxANm, a PCR fragment containing
lpxH was cloned into pMMB67EH-LpxANm. All plasmids were
sequenced at Macrogen (Seoul, Korea). Plasmids were then
used to transform E. coli strains BL21(DE3) and SM10pir for
protein production and for subsequent transfer to B. pertussis,
respectively. The transfer to B. pertussis was performed by con-
jugation using ampicillin and nalidixic acid for selection and
counterselection, respectively.
RNA extraction and RT-PCR
RNA was obtained from exponentially growing cultures as
described previously (22). Pure RNA was used immediately
to generate cDNA using the Transcriptor High Fidelity
cDNA Synthesis Kit (Roche). RNA, cDNA, and genomic
DNA were used as templates in PCRs with the primers listed
in Table S2.
SDS-PAGE and Western blotting
Bacteria from liquid cultures grown to an A600 of 1 for
E. coli or an A590 of 0.5 for B. pertussis were collected by cen-
trifugation, adjusted to an optical density of 5.0, mixed 1:1 with
double-strength sample buffer, and heated for 10 min at 100 °C.
Proteins were separated by SDS-PAGE on gels containing 14%
acrylamide. After SDS-PAGE, proteins were transferred to
nitrocellulose membranes and detected with anti-His6 tag anti-
bodies (Sigma-Aldrich) following procedures described previ-
ously (23).
LPS purification and analysis
LPS was isolated from bacteria with hot phenol–water (24)
and purified further by solid-phase extraction (SPE) on C8
reverse-phase cartridges. Briefly, bacteria were collected from
cultures by centrifugation, suspended in water at 70 °C, and
mixed with 0.8 volumes of phenol at the same temperature.
Figure 5. A and B, stimulation of HEK293-Blue reporter cells expressing hTLR4 (A)
or mTLR4 (B) with purified LPS of strain B213 or mutant derivatives. After incuba-
tion of HEK293-Blue cells with the indicated LPS variants for 17 h, alkaline phos-
phatase activity was determined. Grafts show the log response ratio from three
independent experiments with average and standard deviation (error bars). Sta-
tistically significant differences were analyzed with GraphPad Prism 6. *, p  0.05.
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After separating the aqueous and phenolic phases by centrifu-
gation, the aqueous phase was prepared for SPE by adding one
volume of 0.356 M triethylammonium acetate (pH 7) (solvent
A) and 1⁄3 volume of 2-propanol:water:triethylamine:acetic acid
(70:30:0.03:0.01 (v/v)) (pH 8.9) (solvent B). LPS extracts were
purified simultaneously by SPE on reverse-phase Sep-Pak C8
cartridges (3-ml syringe barrel-type Vac cartridge, 200 mg of C8
resin, Waters) using a 20-position vacuum manifold (Waters).
Cartridges were conditioned for SPE by consecutively applying
3  1 ml of solvent B, 2-propanol:water:triethylamine:acetic
acid (10:90:0.03:0.01 (v/v)) (pH 8.9) (solvent C), 0.07 mM trieth-
ylammonium acetate (pH 7) (solvent D), and solvent A under a
vacuum. Then samples were loaded into the cartridges, and
each cartridge was washed with 3  1 ml of solvents A, D, and C,
in this order. LPS were eluted from the columns by applying 2 
0.3 ml of solvent B. Eluates were dried in a centrifugal vacuum
concentrator and suspended in water. The purity and integrity
of purified samples were judged by Tricine–SDS-PAGE com-
bined with LPS silver and Coomassie staining. Negative-ion ESI
Fourier transform (FT) MS of purified LPS was performed on
an LTQ Orbitrap XL instrument (Thermo Scientific). LPS sam-
ples were dissolved in a mixture of 2-propanol, water, and tri-
ethylamine (50:50:0.001 (v/v/v)) (pH 8.5) and infused into the
mass spectrometer by nano-ESI using gold-coated pulled glass
capillaries (25). The spray voltage was set to from 1.3 to 1.85
kV, and the temperature of the heated capillary was 250 °C.
Under these ionization conditions, no appreciable fragmenta-
tion of LPS was observed. To record lipid A mass spectra, nano-
ESI–FT–MS of LPS was performed with in-source CID at a
potential difference of 100 V. In-source CID under this setting
produced intense fragment ions corresponding to intact lipid A
domains, which originated from the rupture of the labile link-
age between the nonreducing lipid A glucosamine and 3-deoxy-
d-manno-oct-2-ulosonic acid. The lipid A compositions pro-
posed are based on the chemical structure of the LPS from
B. pertussis reported previously (26). Mass-to-charge ratios
given refer to monoisotopic molecular masses.
Singly deprotonated lipid A ions generated by in-source CID
of LPS from B. pertussis B213-pLpxHNm and B. pertussis B213-
pLpxHNm-LpxANm were subjected to tandem MS by CID at a
normalized collision energy of 35% on an LTQ Orbitrap XL
Instrument (Thermo Scientific). Fourier Transform MS/MS
lipid A mass spectra were recorded at a resolution of 60,000 at
m/z 400.
Bioinformatic analysis
Multiple sequence alignment of the LpxH sequences was
performed using the Clustal Omega web portal with default
settings (27). Visualization and coloring of the alignment were
performed using Jalview (28). Homology modeling of LpxH of
B. pertussis was performed using Rosetta 3.8 (29, 30). Briefly,
modeling was based on the structures of LpxH in complex with
lipid X from H. influenzae (PDB code 5K8K) and P. aeruginosa
(PDB codes 5B49, 5B4A, and 5B4B). Sets of 5000 models were
built with either a 3OH-C10 or a 3OH-C14 chain on the 3
position of the ligand. For each of the sets, the best 1000 models
by score were clustered using Calibur (31). Of those, the lowest-
energy structures of the 10 largest clusters were combined into
an ensemble and refined using the Haddock refinement server
(32). All final models were evaluated based on energy and clus-
ter size. Visualization and image generation was done using the
PyMOL Molecular Graphics System provided by SBGrid (33).
TLR4 stimulation assays
Human NF-B/SEAP reporter HEK293-Blue cells trans-
fected with either human or mouse TLR4 in combination with
MD-2 and CD14 (InvivoGen) were used in this study. Both cell
lines contain an NF-B-dependent secreted embryonic alkaline
phosphatase (SEAP) reporter gene, which is expressed after
TLR4 signaling. The cells were grown in HEK-Blue culture
medium as described before (13) at 37 °C in a 5% saturated CO2
atmosphere. For TLR4 activation, HEK-Blue cells (2.5  104)
were incubated with serial dilutions of purified LPS in a 96-well
plate. After 17 h of incubation at 37 °C, supernatants were col-
lected and incubated with 1 mg ml1 of the SEAP substrate
para-nitrophenyl phosphate in 1 M diethanolamine substrate
buffer (pH 9.8), and the A405 was measured using an ELISA
reader. For each strain, the log response ratio was calculated as
the log10 of the ratio between sample and control (nonstimu-
lated cells). Two-way analysis of variance (Dunnett’s multiple
comparison test) was used to analyze the data for statistical
significance.
Antibiotic sensitivity assays
The antibiotic susceptibility of B. pertussis was tested follow-
ing methods described previously (34) with some modifica-
tions. Briefly, serial dilutions of antibiotics were prepared in
PBS, and 50 l of each dilution was transferred to a 96-well
microtiter plate (final antibiotic concentrations ranging from
0.2 g ml1 to 2 mg ml1). B. pertussis strains were grown to
log phase in Verwey medium (A590 of 0.2– 0.6). Bacterial sus-
pensions were then diluted to a final A590 of 0.2 in Verwey
medium, and 50-l aliquots were added to each well in the
microtiter plate and incubated under static conditions for 1 h.
No differences in the A590 of the bacterial cultures were
detected before and after incubation. Then, 50 l of each sam-
ple was diluted, and the number of surviving bacteria was deter-
mined by plating 10-fold serial dilutions onto BG plates. Anti-
biotic concentrations that resulted in a bacterial survival of
20 – 60% and that showed reproducible results were selected
(1 g ml1 of rifampicin, 2 mg ml1 of vancomycin, and 2 g
ml1 of chloramphenicol). For each strain, the number of col-
ony-forming units was relative to the control (no antibiotic).
For each experiment, at least three biological replicates were
performed, and Student’s t test was used to analyze the data for
statistical significance.
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